U.S. Department Of Transportation. Federal Motor Carrier Safety Adminstation.

Contact Us | Site Index | FMCSA | FMCSA Portal | DOT.gov

Training and Testing

Medical Examiners

Drivers and Carriers

FMCSA Medical Examiner Handbook Part I - General FMCSA Information Part II - The Job of Commercial Driving Part III - Medical Examination Guidelines Part IV - Physical Qualification Standards 49 CFR 391.41(b)Standards Review Medical Examination Report Form Review Part IV - Guidance/ Advisory Criteria Available in PDF Conditions Medications Tests Treatments Resources Links to FMCSA Web Site Handbook Map	Part IV - Guidance/Advisory Criteria
	Guidance/Advisory Criteria — Available in PDF
	Cardiovascular Recommendation Tables Only (PDF) Tables Only Last update: February 2009 — Use the CVD Tables Archive to identify changes. Important Note: Periodically check that printed tables are current with last update. Medical Examination Form (PDF)
	Guidance/Advisory Criteria — Conditions
	Abdominal Aortic Aneurysm Other Aneurysms Acute Deep Vein Thrombosis Acute Infectious Diseases Acute Myocardial Infarction Acute Seizures — Structural Insult to the Brain Acute Seizures — Systemic Metabolic Illness Adult Attention Deficit Hyperactivity Disorder Alcoholism Allergic Rhinitis Allergy-related Life-threatening Conditions Angina Pectoris Aortic Regurgitation Aortic Stenosis Asthma Atypical Tuberculosis Autonomic Neuropathy Bipolar Mood Disorder Central Nervous System Tumors CHD Risk-Equivalent — Multiple CHD Risk Factors Chest Wall Deformities Childhood Febrile Seizures Chronic Obstructive Pulmonary Disease Chronic Sleep Disorders Chronic Thrombotic Venous Disease Conditions Associated with Abnormal Muscle Activity Congenital Myopathies Cor Pulmonale Cystic Fibrosis Dementia Diabetes Mellitus Drug Abuse Ebstein Anomaly Embolic and Thrombotic Strokes Epilepsy Essential Hypertension Stage 1 Hypertension Stage 2 Hypertension Stage 3 Hypertension Fixed Deficit of an Extremity Headaches Heart Failure Hernia Hypersensitivity Pneumonitis Hypertrophic Cardiomyopathy Infections of the Central Nervous System Intermittent Claudication Interstitial Lung Disease Intracerebral and Subarachnoid Hemorrhages Major Depression Metabolic Muscle Diseases Mitral Regurgitation Mitral Stenosis Mitral Valve Prolapse Motor Neuron Diseases Muscular Dystrophies Neuromuscular Junction Disorders Nephropathy Other Aneurysms Peripheral Neuropathies Peripheral Vascular Disease Personality Disorders Pneumothorax Pulmonary Emboli Pulmonary Hypertension Pulmonary Tuberculosis Pulmonary Valve Stenosis Restrictive Cardiomyopathy Schizophrenia and Related Psychotic Disorders Secondary Hypertension Single Unprovoked Seizure Stage 1 Hypertension Stage 2 Hypertension Stage 3 Hypertension Superficial Phlebitis Supraventricular Arrhythmias Syncope Thoracic Aneurysm Transient Ischemic Attack Traumatic Brain Injury Varicose Veins Ventricular Arrhythmias Vertigo and Dizziness
	Guidance/Advisory Criteria — Medication
	Anticoagulant Therapy Anticonvulsant Therapy Antidepressant Therapy Antihistamine Therapy Antipsychotic Therapy Anxiolytic and Sedative Hypnotic Therapy Central Nervous System Stimulant Therapy Incretin Mimetic Therapy Insulin Therapy Lithium Therapy Narcotic Antitussive Therapy Non-Insulin Medications
	Guidance/Advisory Criteria — Tests
	Echocardiography Exercise Tolerance Test Grip Strength Tests Measure Blood Pressure and Check Pulse Pulmonary Function Tests Sleep Disorder Tests Urinalysis
	Guidance/Advisory Criteria — Treatments
	Aortic Valve Repair Coronary Artery Bypass Grafting Surgery Electroconvulsive Therapy Implantable Cardioverter-Defibrillators Mitral Stenosis Treatment Mitral Valve Repair for Mitral Regurgitation Pacemakers Percutaneous Coronary Intervention Post-Surgical Repair of Aneurysm Prosthetic Valves

Feedback | Privacy Policy | USA.gov | Freedom of Information Act (FOIA) | Accessibility | OIG Hotline | Web Policies and Important Links | Site Map | Plug-ins

Federal Motor Carrier Safety Administration
1200 New Jersey Avenue SE, Washington, DC 20590 • 1-800-832-5660 • TTY: 1-800-877-8339 • Field Office Contacts